GPT and hepatocellular carcinoma: Clinical assessment, alanine aminotransferase (ALT), age, and family history of HCC are available in most settings, and hepatitis B e-antigen (HBeAg) and HBV DNA might be available at larger centres in low- and middle-income countries.